2nd Health Equity & Outcomes Summit

On-Demand Content | Virtual Event


  • With a big hill to climb, combating health inequity can feel like a long and difficult road, but there are successes seen in various areas within health care
  • Celebrating the successes of various initiatives gives hope and insight into what areas deserve more focus and what inequities and SDoH need a deeper examination
  • By honoring and acknowledging successes and in some cases, failures, we can bring a better awareness and understanding to these topics and showcase the best, most efficient, and fiscally and socially responsible ways we are using our reach and scope to combat inequities within marginalized and underserved communities
Pierre Theodore, Vice President, Public Health, JOHNSON & JOHNSON
RADM Richarde Araojo, Associate Commissioner of Minority Health, Office of Minority Health and Health Equity, FDA
  • Where can industry pros collaborate and improve to address basic SDoH problems and what strategies can be implemented to remove barriers to patient needs
  • How can providers better recognize and then care for/respect health inequities and SDoH when it comes to patients
  • How data, scientific innovation, and digital tools help improve SDOH issues and where best to implement such tools for better patient engagement
Hank Kessler, Vice President, US Franchise Head, Hematology, SOBI
  • Learn about UCB’s approach to health equity and population health in epilepsy
  • Review new projects to address health inequities for people living with epilepsy. Project examples include a community pharmacist-led care initiative, social determinants of health research to investigate treatment delays, and a program to develop culturally relevant support for Hispanic Americans.
  • Explore future opportunities to address health inequities through digital technologies.
Grant Simic, Executive Population Health Partner, UCB
  • Diversity and Inclusion in your workplace goes beyond the hiring process, by understanding and recognizing your employees and patient health needs, you can create a more equitable world around your business
  • Analyzing how best to support both a Diverse and Inclusive patient population and workforce through Equitable Hiring processes and patient centered outcomes is key to ensuring success across your commercial model
  • Providing access to leadership position for Diverse Employees solidifies the opportunities needed to bring about equitable change across your organization and workforce
Janine Jansen Global Diversity, Equity, Inclusion, and Belonging Lead ORGANON
  • Many individuals within marginalized communities have a distrust for those outside their community, especially those within healthcare, because of past experiences and ancestral trauma
  • Finding community members that potential patients trust and rely on is the key to reaching these individuals while also providing access to key therapies and building new relationships
  • Creating new relationships with marginalized communities should be at the intersection of health equity and fiscal responsibility
Iris Lundy, Director, Health Equity, SENTARA HEALTHCARE
  • Overview of the Canadian HC system reimbursement and access for new therapies
  • Discuss the importance of RWE in decision-making and its impact.
  • An overview of recent trends by payers to manage price and access; lessons learnt from Canada – Implications for US payer systems
Farah Jivraj, Head of Market Access and Stakeholder Relations, BIOGEN
  • Health Equity and HEOR are integral parts of understanding the health system. When both are worked on collaboratively, many aspects of the system including patient and payer strategies are positively supported
  • Understanding the economic impact positive patient outcomes can have on marginalized populations open avenues to more diverse patient populations, data streams, and potentially gainful payer opportunities
  • Increase in positive patient outcomes also means an increase in health system growth and researching potential stop-gaps and future roadblocks through HEOR allows a more actionable and deliverable future archetypes
Darshini Shah, Director, HEOR, ABBVIE
  • Two key components of successful health equity solutions include meaningful collaboration and long-term sustainability.
  • Join Lauren Powell, M.P.A., Ph.D., VP, U.S. Health Equity & Community Wellness at Takeda, in discussing the importance of building authentic relationships to co-design health equity solutions that reflect the needs and challenges of a given population, and engaging with local communities to help build capacity and create initiatives that drive generational impact.
Lauren Powell, Vice President US Health Equity and Community Wellness, TAKEDA
Alexandra (Alex) Quinn, CEO, HEALTH LEADS
Denard Cummings, Director of Equitable Health System Integration, AMERICAN MEDICAL ASSOCIATION
Michael Crawford, Associate Dean for Strategy Outreach and Innovation, HOWARD UNIVERSITY COLLEGE OF MEDICINE
  • Many Companies in the pharma industry support Health Equity and Patient Outcomes programs philanthropically but have trouble finding the equilibrium between fiscal achievement and social change
  • Having those tough conversations in the industry will provide professionals with the tools and information they need to create real change across their workforce and patient outcomes influence
  • Understanding the benefits of moving outside traditional “comfort zones” to speak on real issues legitimizes years of work, research and effort and supplies the public with a more real world view of the pharma world
Josette Gbemudu, Executive Director, Health Equity, MERCK AND CO.
Xavior Robinson, Director, Health Equity Partnerships and Operations, MERCK AND CO.
Ava Skolnik, Associate Director, Health Equity Programs and Partnerships, MERCK AND CO.
  • What does invisible disability inclusivity look like in person and digitally?
  • How can it lead to a more equitable healthcare system?
  • How can it influence the pharmaceutical industry?
  • How can it impact the workforce?
  • In the past, BIPOC people’s have seen the healthcare system as a potentially dangerous place, with many ancestors being used for medical experiments or treated harshly by the healthcare system
  • Creating a welcoming and safe environment can improve trust between marginalized communities and the health system
  • Greater diversity within clinical trials also open patient pools to a wider variety of patients and potential connections between diseases and underserved communities
Kim Fookes, Global Head of Diversity and Inclusion in Clinical Trials, NOVARTIS
  • Mental Health has been a tough topic to address in the U.S. and around the world, and the COVID-19 pandemic only exasperated the issues and problems surrounding Mental Health and Health Equity on a global scale
  • Psychedelics and various Non-Traditional Therapies offer both actionable results and a realistic return when it comes to Payer Strategies when Psychedelics are covered in coverage models, leading to more inclusive health equity
  • Opening access to coverage for Drug-Therapy Modalities and Psychedelics will lead to access for underserved and marginalized populations that in turn, open pathways to provider and payer satisfaction and reimbursement
Theresa Gorenc, Head of Market Access, MAPS PUBLIC BENEFIT CORPORATION